Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Millennium Pharmaceuticals, Inc.
Genentech, Inc.
Information provided by (Responsible Party):
William Walsh, University of Massachusetts, Worcester
ClinicalTrials.gov Identifier:
NCT00424840
First received: January 18, 2007
Last updated: November 5, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2014
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)